ClinicalTrials.gg
Sign In

Coronary Restenosis clinical trials

The registry lists 107 studies for Coronary Restenosis across more than 10 countries. 10 are recruiting or about to start. 30 of them are mainly about Coronary Restenosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-20.

Get an email when these change. Save the Coronary Restenosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
74
Status unknown
14
Recruiting
8
Terminated
4
Withdrawn
2
Not yet recruiting
2

Phase

Phase 4
20
Phase 3
13
Phase 2
12
Phase 1
4

Where

United States
30
Germany
25
Netherlands
20
France
15
Italy
15
Switzerland
14

Who runs them

Abbott Medical Devices (39) · Peking Union Medical College Hospital (4) · Foundation of Cardiovascular Research and Education Enschede (4) · Deutsches Herzzentrum Muenchen (3) · Thorax Centrum Twente (2) · Luzerner Kantonsspital (2) · Biosensors Europe SA (2) · University Hospital, Saarland (2)

What is being tested here

Drugs under test in Coronary Restenosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Sirolimus002
Albumin-Bound Paclitaxel001
Paclitaxel001
Insulin001
Thalidomide001
Pioglitazone011
Celecoxib001
Everolimus011

Drug classes tested here mTOR inhibitors 3

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 8 Coronary Restenosis studies recruiting now, 7 (88%) set no upper age limit and 1 (13%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 8
AgeWomenMen
100 (0%)0 (0%)
187 (88%)7 (88%)
307 (88%)7 (88%)
407 (88%)7 (88%)
508 (100%)8 (100%)
657 (88%)7 (88%)
757 (88%)7 (88%)
857 (88%)7 (88%)

Across all 107 studies, recruiting or not: 7% stop at 75 or younger and 1% at 65; 7% take children; 2% are for women only and 0% for men only; 1% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Coronary Restenosis studies take

Of 13 interventional studies with no phase under Coronary Restenosis, half reached primary completion within 44 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase44 mo28–61 · 13 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 107. Browse all 107 → or search them.